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Abstract.  Cell-cell adhesion is controlled by many 
molecules found on the cell surface. In addition to the 
constituents of well-defined junctional structures,  there 
are the molecules that are thought to play a role in the 
initial  interactions  of cells and that appear at precise 
times during development. These include the cadher- 
ins and cell adhesion molecules (CAMs).  Representa- 
tives of these families of adhesion molecules have 
been isolated from most of the major tissues. The no- 
table exception is the vascular endothelium.  Here we 
report the identification of a cell surface molecule desig- 
nated "endoCAM" (endothelial Cell Adhesion M__ole- 
cule), which may function as an endothelial cell-cell 
adhesion molecule. EndoCAM is a  130-kD glycopro- 
tein expressed on the surface of endothelial cells both 
in culture and in situ.  It is localized to the borders of 
contiguous endothelial cells. It is also present on 
platelets and white blood cells. Antibodies against en- 
doCAM prevent the initial formation of endothelial 
cell-cell contacts.  Despite similarities  in size and in- 
tercellular location, endoCAM does not appear to be a 
member of the cadherin family of adhesion receptors. 
The serologic and protease susceptibility characteris- 
tics of endoCAM are different from those of the 
known cadherins,  including an endogenous endothelial 
cadherin.  Although the precise biologic function of 
endoCAM has not been determined,  it appears to be 
one of the molecules responsible for regulating endo- 
thelial cell-cell adhesion processes and may be in- 
volved in platelet and white blood cell interactions 
with the endothelium. 
T 
HE lining of blood vessels is formed by the close struc- 
tural apposition of individual endothelial cells forming 
a  polarized,  nonthrombogenic,  permeability barrier 
resting on an underlying basement membrane. This vascular 
lining is established during development by the formation of 
distinct junctional complexes  between individual  cells and 
between cells and their extracellular  matrix.  Morphological 
studies  have demonstrated the presence of tight junctions, 
adherens junctions and gap junctions between adjacent endo- 
thelial cells (Schneeberger and Lynch, 1984; Franke et al., 
1988),  and immunochemical  analysis  has shown that  inte- 
grins probably play a major role in anchoring  the cells to 
their basement membrane (Albelda et al.,  1989). 
The assembly of cells into a flattened polarized layer of tis- 
sue requires specific cell-cell interactions.  For example,  in 
the developing  mouse embryo, compaction must occur be- 
fore blastomere polarity can develop and before the junc- 
tional complexes required for blastocyst formation can be as- 
sembled (Richa et al.,  1985; Fleming  and Johnson,  1988). 
In cultured epithelial  cells, Pasdar and Nelson (1988) have 
shown that junctional complexes form rapidly after initial 
cell-cell contact.  If epithelial  cell-cell junctions are dis- 
rupted by lowering  the Ca  2÷ concentration,  the junctional 
complexes separate and disappear.  Junctional  complexes re- 
appear as the cells reaccumulate cadherin-rich  sites within 
the membrane. Their reformation can be blocked by antibod- 
ies against a member of the cadherin  family (Behrens et al., 
1985; Gumbiner et al., 1988). These and other studies imply 
that members of the cadherin family of receptors play a part 
in initiation,  assembly, and maintenance  of polarity of intact 
monolayers of epithelial cells (Gumbiner et al., 1988; Takei- 
chi,  1988).  Although  the cadherins  are important  in  the 
maintenance  of cell-cell interactions,  it is also possible that 
the calcium-independent  adhesion  proteins,  represented by 
the neural cell adhesion molecule N-CAM/may be involved 
(Edelman,  1988;  Rutishauser  and Jessel,  1988).  Like the 
cadherins,  N-CAM, originally  described in nervous tissue, 
is expressed transiently  in many tissues during embryonic 
development and is also thought to provide important infor- 
mation for cellular  association. 
Despite the widespread expression  of CAMs and cadher- 
ins in most tissues,  no molecules in endothelial  cells have 
been described that might provide the positioning  cues nec- 
essary for angiogenesis  or the establishment of a polarized, 
nonpermeable vascular lining (Takeichi, 1988; Heimark and 
Schwartz,  1988;  Hatta et al.,  1985).  Here, we report the 
identification of a cell surface molecule that may participate 
in such a function.  The molecule, which we designate as en- 
1. Abbreviations used in this paper:  DFP, diisopropylfluorophosphate; en- 
doCAM, endothelial Cell Adhesion Molecule; N-CAM, neural cell adhe- 
sion molecule; TNC, 0.01 M Tris acetate,  pH 8.0, 0.5%  NP-40, 0.5 mM 
Ca2+; WGA, wheat germ agglutinin. 
© The Rockefeller University Press, 0021-9525/90/04/1227/I 1 $2.00 
The Journal of Cell Biology, Volume 110, April 1990 1227-1237  1227 doCAM, is expressed on the surface of endothelial cells in 
culture and in situ, where it is found on both capillary and 
major vessel endothelium. EndoCAM is a  130-kD cell sur- 
face protein that differs from the cadherins both serologically 
and in its susceptibility to proteases.  Although its precise 
biological functions have not been determined, antibodies 
against endoCAM block endothelial association, suggesting 
it is involved in the intercellular adhesion of endothelial cells. 
In addition, since this molecule appears on platelets and some 
white blood cells, it may also play a role in platelet-leuko- 
cyte-endothelial adhesion. 
Materials and Methods 
Cell Culture 
Endothelial cells were isolated, cultured, and characterized from bovine fe- 
tal aortae, human adult lilac arteries or veins, or human umbilical veins as 
previously described (Rosen et al., 1983; Thornton et al., 1983; Jerrell et 
al., 1984; Albelda et al., 1989).  Briefly, vessel segments were cannulated, 
incubated with 1 mg/ml collngenase for 10 rain and the detached cells were 
plated into gelatinized tissue culture flasks. Bovine cells were cultured in 
F12 media supplemented with 10% heat-inactivated FBS. Human endothe- 
lial cells were cultured in medium 199 containing 15% heat-inactivated  FBS, 
75-100 ~g/ml endothelial cell growth factor, 100 ttg/ml heparin, and 2 mM 
L-glutamine. The media used for initial isolations also contained 100 t~g/ml 
gentamycin and 4/~g/ml amphotericin B, however, no antibiotics were used 
after primary isolation. Endothelial cell identity was confirmed by morphol- 
ogy, by immunofluorescent staining for Factor VIII-related antigen, and by 
detection of angiotensin-converting enzyme activity (Rosen et al.,  1983). 
Madin-Darby bovine kidney epithelial cells (MDBK cells) and human 
U937  cells were obtained from the American Type Culture  Collection 
(Rockville, MD). All cultures were incubated at 37"C in a humidified 5% 
CCh atmosphere. At confluence, cells were subcultured by treatment with 
trypsin (0.25%)/EDrA (0.4%) in HBSS. All cultures were tested periodi- 
cally and found to be free of mycoplasma infection. 
Platelet Purification 
Bovine blood, collected in 3.8% sodium citrate, was centrifuged at 750 g 
for 15 rain to produce platelet-rich plasma (PRP). The pH of the PRP was 
adjusted to 6.5 with citric acid to prevent aggregation and the platelets pel- 
leted by centrifugation at 2,500 g  for 10 rain. After washing, the platelet 
pellet was extracted as described below. 
Antibodies 
mAb to bovine endoCAM (Jaffe et al., 1987) was prepared as culture super- 
natant or from mouse ascites. Polyclonal antiserum to endoCAM was pre- 
pared as described below.  An antiserum produced against a synthetic pep- 
tide  containing  the  20  carboxy-terminal  amino  acids  of A-CAM  was 
provided by Dr.  Benjamin Geigar (Weizman Institute, Rehovot, Israel). 
This antisera cross-reacts with all of the known cadherins. A mAb against 
CD31  was generously provided by Dr. Jan Sixma (University Hospital, 
Utrecht, The Netherlands). 
Cell Harvest and NP-40 Extractions 
After achieving confluence in geiatinized 75-cm  2 tissue culture flasks, en- 
dothelial cells were harvested by scraping. Cell pellets of "~5  ×  107 cells 
were frozen at -70°C. Membrane extracts were prepared by adding small 
amounts (i.e. two to three times the volume of the cell pellet) of  0.01 M Tris 
acetate, pH 8.0, 0.5%  NP-40,  0.5 mM Ca  2+ (TNC) with 2 mM PMSF to 
the pellet, pipetting on ice for 15 min, and then centrifuging for 30 min at 
12,000 g. The resulting supernatant was designated the nonionic detergent 
extract and frozen at -70°C until used. Some extractions were performed 
in TNC with addition of 5 mM EDTA, 1 #g/ml leupeptin, I #g/ml pepsta- 
tin,  and5  mM  diisopropylfluorophosphate (DFP)  (all  purchased  from 
Sigma Chemical Co., St.  louis, MO). 
Purification of  Bovine EndoCAM 
Bovine endoCAM was purified using a combination of lectin affinity and 
mAb affinity chromatography techniques as previously described (Albelda 
et al., 1989).  Briefly, a water jacketed column (1  ×  30 era) containing 1.5 
ml of wheat germ agglutinin (WGA) coupled to Sepharose beads (E.Y. Labo- 
ratories, San Mateo, CA) was equilibrated in TNC buffer containing 0.15 
M NaCI. Nonionic detergent extracts from bovine endothelial cells were ap- 
plied to the column. The column was washed extensively with TNC/0.15 
M NaCI. Bound material was eluted using 0.2 M N-acetyl-o-glucosamine 
in TNC buffer in  1 ml fractions, which were monitored for the presence 
of endoCAM by immunoblotting. 
Fractions from the WGA column that contained endoCAM were pooled 
and applied to a water jacketed column containing 1 ml packed volume of 
anti-endoCAM mAb Oaffe et al., 1987) coupled to cyanogen bromide sepia- 
arose (5 mg antibody/ml of Sepharose). After extensive washing with TNC 
buffer, bound material was eluted with l-ml fractions of  a solution of 50 mM 
diethylamine in 0.01 M Tris acetate, 0.5 mM Ca  2+, 0.05%  NP40 adjusted 
to pH  11.5. Each fraction was neutralized, dialysed against TNC/0.15  M 
NaCI overnight at 4°C, and analyzed by SDS-PAGE followed  by silver stain- 
ing. When material was used for the blocking assay (see below), detergent 
was removed using SM 2 Biobeads (Bio-Rad Laboratories, Richmond, CA) 
as previously described (Knudsen et al.,  1981). 
Preparation of Polyclonal Anti-endoCAM Antiserum 
Purified endoCAM obtained from the mAb column was injected into rabbits 
to prepare a  monospecific polyclonal anti-endoCAM antiserum.  Rabbits 
were initially injected subcutaneously with 100/~g of protein suspended in 
CFA. Subsequent injections of 50 t,  tg of purified endoCAM suspended in 
incomplete adjuvant were made at 10-d intervals for a total of seven injec- 
tions. Rabbit serum was tested for activity by immunoblotting and immuno- 
precipitation against bovine and human endothelial cell extracts. 
Labeling of Cells 
For [2Sl-labeling, intact monolayers of cells in 75--cm  2 tissue-culture flasks 
were washed with PBS and exposed sequentially to 100 O/ml of lactoperox- 
idase (Sigma Chemical Co., St.  Louis, MO),  1 mCi of carrier-free 125I 
(Amersham Chemical Co., Arlington Heights, IL), and three, 40-~1 aliquots 
of 0.06%  hydrogen peroxide. The cells were harvested and extracted as de- 
scribed above. 
For 3sS labeling, ceils in 75-cm  2 flasks were washed with PBS and then 
exposed to DME without methionine in the presence of dialyzed 10% FBS 
for 1 h. Fresh media containing 250 izCi of [35S]methionine  (New England 
Nuclear, Boston, MA) was then added. After 24 h, the cells were harvested 
and extracted as described above. 
Immunoprecipitation 
Nonionic detergent extracts were preadsorbed for 30 min at 4°C with Pro- 
tein A conjugated to Sepharose beads (Pharmacia Fine Chemicals, Piscat- 
away, NJ). The appropriate antibody was then added to the extract for I h 
at 4*C.  Immunocomplexes were collected by precipitation with Protein 
A-Sepharose  beads for 1 h at 4"C, washed five times with a buffer containing 
50 mM Tris-HCl (pH 7.5),  150 mM NaCI,  1% Triton X-100, 5% deoxy- 
cholate, and 0.1% SDS. The sample was then dissolved in electrophoresis 
sample buffer (62.5 mM Tris base, 2 % SDS, 10% glycerol, pH 6.8), electro- 
phoresed on 7% polyacrylamide gels and processed for autoradiography as 
described below. 
Gel Electrophoresis and lmmunoblotting 
Samples were analyzed by SDS-PAGE using 6% polyacrytamide gels by the 
method of Laemmli (1970)  without the use of reducing agents. Gels were 
dried and exposed to Kodak XR-5 x-ray film at -70"C, processed for West- 
ern immunoblotting or stained for protein using the silver nitrate reagent 
and methods previously described (Albelda et al., 1989).  For immunoblot 
analysis, an alkaline phosphatase-coupled secondary antibody (Promega 
Biotec, Madison, WI) was used to detect specific antibody binding to pro- 
teins on nitrocellulose paper. 
Trypsin and Calcium Sensitivities of 
Cell Adhesion Molecules 
To test endoCAM sensitivity to degradation by varying concentrations of 
trypsin in the presence and absence of calcium ions,  confluent 25-cm  2 
flasks of bovine endothelial cells and bovine epithelial cells (MDBK cells) 
were incubated at 37°C for L5 min in 2.5 ml of one of the following four 
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cais, Freehold, NJ) plus 1 mM EGTA (TE); (c) 0.0001% trypsin plus 1 mM 
EGTA (LTE); or (d) 0.01%  trypsin plus  10 mM CaCI2  (TC)  in  10 mM 
Hepes-buffered saline (Takeichi, 1977). 5 ml of 0.05 % soybean trypsin in- 
hibito  r (Worthington Biochemicals) was added to each flask, cells were har- 
vested, washed twice, and extracted in TNC/PMSF as described above. Ex- 
tracts  were  subjected  to  SDS-PAGE,  transferred  to  nitrocellulose  and 
immunoblotted with anti-endoCAM or anti-cadherin antibodies. 
Bioassay 
To test the effect of polyclonal anti-endoCAM antibodies on the establish- 
ment of cell-cell adhesion, bovine endothelial cells were treated for 3 min 
at 37°C with trypsin (0.25%)/EDTA (0.4%) and plated at a density of 7.5 
×  104 cells/cm  2 into 2 cm  2 tissue culture wells in 1 mi of F12 media con- 
taining 10%  serum. After allowing cell adhesion to proceed for 1 h, 700 
/~1 of media was removed and varying amounts of preimmune rabbit serum 
or anti-endoCAM antisera were  added.  After  18 h,  the cell  layers were 
washed once and photographed. 
Blocking Assay 
To confirm the specificity of our polyclonal antibody effects, endothelial 
cells were observed in the presence of antibody plus highly purified endo- 
CAM. Endothelial cells were plated as above. After 1 h, 850 t~l of media 
was removed and replaced with 150 ~1 of material eluted from the mAb col- 
umn that had been rendered detergent-free via treatment with Biobeads. As 
a control, buffer from a fraction of the column that contained no endoCAM 
by silver staining or immunoblotting was used. Anti-endoCAM antibody 
was added at a dilution of 1:50  and the cells observed and photographed 
after  18 h. 
lmmunofluorescence 
Endothelial  cells  were  plated  at  4  ×  104  cells/cm  2 on glass coverslips 
coated with 10 t~g/ml of human fibronectin (Bethesda Research Laborato- 
ries, Bethesda, MD) or  1%  gelatin in PBS (Difco Laboratories, Detroit, 
MI). After the cells had grown to confluence, fixation and staining was per- 
formed using previously described methods (Aibelda et al., 1989). Briefly, 
cells were fixed with 3 % paraformaldehyde for 20 rain and then permeabil- 
ized with 0.5% NP40 for 1 min. After extensive washing, 50/~1 of antibody 
or preimmune serum was added for  1 h, and after rinsing, the coverslips 
were  stained  with  50  /~1  of  a  1:200  dilution  of  fluorescein-labeled 
anti-mouse or anti-rabbit antibodies for 1 h. Cells were viewed on a Zeiss 
phase-epifluorescent microscope using a 63x  planapochromat oil-immer- 
sion lens NA  1.4 and photographed using Tri-X film at 400 ASA. 
Results 
Identification of  an Endothelial CeU-CeU Adhesion 
Molecule (EndoCAM) 
An mAb (D2) has been previously described which reacts 
with a  130-kD protein on the surface of bovine endothelial 
cells (Jaffe et al.,  1987).  The protein is  found mainly at 
cell-cell borders and hence is a good candidate for a mole- 
cule which plays a role in establishing cell-cell interactions. 
To examine this possibility, the protein was purified from a 
nonionic detergent extract of bovine endothelial cells by a 
combination of wheat germ and mAb affinity chromatogra- 
phy. The purified protein was then injected into rabbits to 
produce a  broad-spectrum anti-endoCAM antiserum.  The 
specificity of this antiserum is shown in Fig.  1. ~25I-surface- 
labeled bovine endothelial cells were extracted with TNC 
and aliquots were immunoprecipitated with preimmune se- 
rum (Fig.  1, lane B), the polyclonal anti-endoCAM (Fig.  1, 
lane C), or the mAb D2 (Fig. 1, lane D). The polyclonal anti- 
endoCAM immunoprecipitated a single 130-kD protein that 
migrated in precisely the same region on SDS-PAGE as that 
precipitated by the D2 monoclonal antibody. A similar pro- 
tein was immunoprecipitated from extracts of human adult 
Figure 1. Immunoprecipitation of extracts from bovine and human 
endothelial cells using anti-endoCAM antibodies. Immunoprecipi- 
tates  of nonionic detergent extracts from ~25I-labeled  endothelial 
cells were isolated and subjected to SDS-PAGE and autoradiogra- 
phy. Lane A, unprecipitated extract from bovine endothelial cells; 
lane B, precipitate of bovine endothelial cell extract using preim- 
mune control serum; lane C, immunoprecipitate of  bovine endothe- 
lial cell extract using polyclonal anti-endoCAM; lane D, immuno- 
precipitate  of bovine endothelial cell  extract  using monoclonal 
anti-endoCAM; lane E, immunoprecipitate of human endothelial 
cell  extract  using polyclonal  anti-endoCAM.  Molecular  mass 
markers designated in kilodaltons are on the left. 
endothelial cells (Fig. 1, lane E). Further evidence that these 
antibodies reacted with the same molecule was provided in 
immunoclearing experiments described below. 
EndoCAM Is Localized to Endothelial 
Cell-CeU Borders 
To further confirm the fact that the polyclonal anti-endoCAM 
reacted with the same material as the mAb, endothelial cells 
were examined by immunofluorescent microscopy using both 
antibodies. As can be seen in Fig. 2 A, polyclonal anti-endo- 
CAM reacted with a protein concentrated at the borders be- 
tween closely apposed bovine endothelial cells. The concen- 
trated staining was seen only at sites of cell-cell adhesion. 
Under identical conditions, preimmune serum from the same 
rabbit did not react with bovine endothelial cells (Fig. 2 B). 
The polyclonal antibody displayed similar  reactivity with 
cultured human endothelial cells (Fig. 2,  C and D). These 
patterns are identical to those seen in bovine endothelial cells 
stained with the monoclonal antibody D2 (Jaffe et al., 1987). 
A similar staining pattern was noted in frozen sections of 
bovine tissue (Fig. 3). In this case, a section through the bo- 
vine thymus showed cells lining a  small artery and a large 
vein. In both cases, the anti-endoCAM-stained material lo- 
calized primarily between adjacent cells.  Thus, endoCAM 
was found concentrated at intercellular contacts both in cul- 
ture and within tissue. EndoCAM was expressed only by en- 
dothelial cells of the vessel lining. This is evident in Fig. 3 
where no anti-endoCAM reaction was noted with mesenchy- 
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tured endothelial cells by indirect immuno- 
fluorescence. Bovine aortic endothelial cells 
(A and B) or human umbilical vein endothe- 
lial cells (C and D) were grown to conflu- 
ence  on coverslips.  The cells  were  fixed, 
permeabilized,  and exposed  to anti-endo- 
CAM polyclonal antibody (A and C) or pre- 
immune rabbit serum (B and D). The cells 
were  then  treated  with  FITC-conjugated 
anti-rabbit  antibodies  and  photographed 
through a microscope equipped for epifluo- 
rescence (xl,600). Arrow: areas where the 
cells are not in contact  show no immuno- 
fluorescence. 
mal or smooth muscle cells of the artery.  In sections from 
other bovine tissues, no material reacting with anti-endoCAM 
was seen on epithelial cells. 
Requirement of  EndoCAM  for the Establishment of 
Initial Cell-Cell Interactions 
The  intercellular  location  of endoCAM  suggested  that  it 
might function in the establishment or maintenance of endo- 
thelial cell-cell interactions. If  this were the case, antibodies 
against endoCAM  should prevent the association of endo- 
thelial cells with one another in much the same manner as 
anti-cadherins have been shown to interfere with epithelial 
cell-cell adhesion (Damsky et al.,  1983).  To examine this 
possibility, bovine endothelial cells were plated in the pres- 
ence  of preimmune  serum  (Fig.  4  A)  or  polyclonal anti- 
endoCAM (Fig. 4 B). The following day,  the cultures were 
examined for the extent of cell-cell association that had oc- 
curred.  In the presence of preimmune serum, the expected 
monolayer of closely associated endothelial cells was formed. 
In contrast, in the presence of anti-endoCAM, the monolayer 
was almost fibroblastic in appearance, showing no signs of 
the close cellular associations characteristic of endothelial 
cells. The antibody effect was completely reversible, thereby 
ruling out antibody-induced toxicity.  To confirm the  spec- 
ificity of the effect of the polyclonal antibody, highly purified 
endoCAM (see Fig. 8 E) was added simultaneously with the 
anti-endoCAM antibody. The purified material inhibited the 
ability of the antibody to disrupt cell-cell interaction (Fig. 
4  C).  Control material from a similarly treated fraction of 
the  mAb column which  contained  no purified endoCAM, 
did not block the anti-endoCAM effect (Fig. 4 D). These re- 
suits indicate that endoCAM may be involved in the estab- 
lishment of cell-cell interactions in endothelial cells. 
Comparison of  endoCAM to Other Cell 
Adhesion Molecules 
Size, intercellular location, and involvement in cell-cell ad- 
hesion suggested that endoCAM might be similar to either 
the cadherins (Takeichi,  1988)  or a molecule previously re- 
ported to be present on platelets, some white blood cells and 
at the intercellular junctions of endothelial cells that has sub- 
sequently  been  designated  as  CD31  (van  Mourik  et  al., 
1985;  McMichael et al.,  1987). 
For the purpose of these comparisons, nonionic detergent 
extracts were prepared from bovine endothelial cells, bovine 
kidney epithelial cells (MDBK), and bovine platelets.  The 
extracts were subjected to SDS-PAGE and immunoblotted 
using antisera reactive with the particular proteins in ques- 
tion.  The monoclonal and polyclonal anti-endoCAM  anti- 
bodies reacted strongly with 130- and 120-kD material in the 
extracts of endothelial  cells (Fig.  5,  middle and right).  In 
contrast,  these antibodies failed to react with any material 
in the MDBK extracts (Fig. 5, middle and right). In addition, 
the monoclonal anti-endoCAM antibody reacted with a pro- 
tein of similar size in an extract of bovine platelets (Fig. 5, 
middle).  The presence of cadherins  in the various cell ex- 
tracts was confirmed using an anti-cadherin antiserum pro- 
duced  against a  peptide corresponding to the cytoplasmic 
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vine tissue. Cryostat sections of bovine thy- 
mic  tissue  were  labeled  with  endoCAM 
mAb and counterstained with FITC-conju- 
gated anti-mouse  antibodies.  (Top) Phase 
micrograph of a  thymic artery (left) and 
vein  (right).  (Bottom)  immunofluorescent 
micrograph of same section demonstrating 
that endoCAM localized only to the endo- 
thelial  layer of each  vessel (arrows).  No 
staining of smooth muscle, intima, or thy- 
mic parenchyma is seen. 
domain of  A-CAM or N-cadherin (Takeichi, 1988). The con- 
served nature of the cytoplasmic domain allows the antibody 
to react with all known cadherins.  The anti-cadherin anti- 
body reacted with molecules of similar size in extracts from 
both MDBK and endothelial cells (Fig. 5,  left). 
Both 130- and 120-kD material was detected in nonionic 
detergent  extracts  that  reacted  with  anti-endoCAM.  The 
amount of this material varied from preparation to prepara- 
tion depending upon extraction conditions suggesting that it 
represented breakdown products of the  130-kD molecule. 
This was confirmed by comparing immunoblots of bovine 
endothelial cells extracted in the presence of PMSF alone or 
with a mixture of protease inhibitors (Fig. 6). The mixture 
of protease inhibitors markedly reduced the amount of 120- 
kD material reactive with either monoclonal or polyclonal 
endoCAM (Fig. 6,  lane A and B vs.  lane C). 
Because both anti-cadherin and anti-endoCAM antibodies 
reacted with 130-kD proteins in endothelial cell extracts, it 
was impossible to determine if they were reacting with the 
same or different molecules, even though anti-endoCAM did 
not recognize any material in the MDBK extracts. Therefore, 
endoCAM  was  isolated from endothelial cells,  and equal 
amounts of material were subjected to SDS-PAGE. Portions 
of the gel were either silver stained or transferred and subse- 
quently immunoblotted using anti-endoCAM and anti-cad- 
herin antibodies. As is shown in Fig. 7, both the polyclonal 
anti-endoCAM  (Fig.  7 A) and monoclonal anti-endoCAM 
(Fig. 7 B) reacted with the purified endoCAM. No reactivity 
was seen using preimmune serum (Fig. 7 C) or anti-cadherin 
antibody (Fig.  7  D).  Some presumed breakdown products 
were noted reacting with the polyclonal anti-endoCAM and 
to some extent with the monoclonal anti-endoCAM.  This 
material was not visible in silver-stained preparations of the 
purified endoCAM (Fig.  7 E). 
To  further  confirm  that  the  anti-endoCAM  and  anti- 
cadherin antibodies were reacting with different molecules, 
A|bclda eta|. Endothelial  CelI-CeU Adhesion Molecule  1231 Figure 4. Effect of anti-endoCAM antibodies on the establishment of  endothelial cell-cell interactions. Bovine aortic endothelial cells were 
plated in the presence of preimmune serum (A), or anti-endoCAM antiserum (B, C, and D). After 24 h, the cells were photographed. 
In the presence of preimmune serum (A), the cells adhere well and form a typical "cobblestone"-appearing monolayer. In contrast, in the 
presence of anti-endoCAM antibody (B), the endothelial cells adhere normally to the plate but fail to establish cell-cell contacts and take 
on a "fibroblastoid" appearance. When a preparation of endoCAM purified by monoclonal affinity column was added concurrently with 
the anti-endoCAM antiserum, the cell-cell inhibitory effect was blocked (C). Addition of material obtained from the same affinity column, 
yet lacking detectable endoCAM, had no blocking effects (D). 
immunoclearing experiments were performed. Extracts from 
endothelial cells were exhaustively preadsorbed with the anti- 
endoCAM mAb or a control, irrelevant monoclonal antibody 
of  the same IgG class (Fig. 8). Unadsorbed extracts and sam- 
pies of the extract adsorbed with each of the antibodies were 
subjected to SDS-PAGE (nonreduced) and then immunoblot- 
ted with anti-endoCAM mAb (left),  anti-endoCAM polyclo- 
nal antibody (middle) or anti-cadherin antibody (right). Pre- 
adsorbtion with anti-endoCAM mAb completely removed 
any material in the 120-130-kD region of  the gel that reacted 
with either anti-endoCAM antibody (Fig. 8, left and middle), 
confirming that both the monoclonal and polyclonal antibody 
react against the same molecular species. The bands visible 
in lane B of the left panel of Fig.  8 do not represent endo- 
CAM, but residual murine antibody identified by the second- 
ary alkaline phosphatase-coupled anti-mouse IgG antibody 
used for the immunoblot analysis. In contrast to the total re- 
moval of  endoCAM by the monoclonal antibody, material re- 
active with anti-cadherin antibody remained in all extracts 
(Fig.  8, right). 
One characteristic feature of  the cadherin family of  cell ad- 
hesion proteins is a  sensitivity to degradation by trypsin, 
which can be blocked by the addition of calcium ions to the 
reaction mixture (Takeichi, 1988). EndoCAM was examined 
for  similar  properties.  Monolayers of bovine endothelial 
cells were exposed to EGTA, EGTA and trypsin, or trypsin 
plus Ca  2+ for  15 min.  The cells were then extracted with 
NP-40 and the extracts subjected to SDS-PAGE. Either en- 
doCAM  or the endogenous cadherin was  identified using 
anti-endoCAM or anti-cadherin antibodies, respectively. As 
a positive control, monolayers of MDBK cells were exposed 
to identical conditions. The immunoblots of epithelial cell 
extracts with anti-cadherin antibody clearly showed proteins 
of 130 kD in EGTA and trypsin/calcium-treated cells (Fig. 
9 A, lanes E and TC) but not in cells treated with either 0.01% 
or 0.0001%  trypsin in the presence of EGTA (Fig. 9 A, lanes 
TE and LTE).  Thus, as expected, the MDBK cadherin was 
protected from trypsin digestion by the presence of calcium. 
In contrast, the immunoblots of extracts from EGTA treated 
endothelial  cells  prepared  using  anti-endoCAM  antibody 
(Fig. 9 B) showed that the 130- and 120-kD bands reactive 
with this antibody (Fig. 9 B, E), were sensitive to digestion 
by trypsin in the presence (Fig. 9 B, /U) and absence (Fig. 
9 B, TE) of calcium. Unlike the epithelial cadherin, endo- 
CAM was resistant to degradation by low concentrations of 
trypsin (0.0001%) in the presence of EGTA (Fig. 9 B, LTE). 
When the immunoblots of the endothelial cells were per- 
formed using anti-cadlaerin, somewhat different results were 
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thelial  cells and  platelets using  anti-endoCAM  antibodies.  Non- 
ionic detergent extracts of bovine aortic endothelial cells (A), bo- 
vine  kidney  epithelial  cells  (B),  or  bovine  platelets  (C)  were 
subjected to SDS-PAGE, transferred to nitrocellulose and then im- 
munoblotted with an anti-pan-cadherin antibody (lejf), monoclonal 
anti-endoCAM  antibody (middle)  or polyclonal antibody against 
endoCAM (right).  The anti-cadherin antibody recognizes a 130-kD 
protein on both endothelial and epithelial ceils.  In contrast,  anti- 
endoCAM antibodies do not react with epithelial cells, but do rec- 
ognize proteins of identical  mass in endothelial  and platelet ex- 
tracts. 
noted (Fig.  9  C).  No material was visible after either tryp- 
sin/EGTA,  low  trypsin/EGTA  or  trypsin/CA  2÷  treatment. 
This suggests that the endothelial  cell cadherin-like  protein 
behaved  in  a  manner  similar  to that  reported  for A-CAM 
Figure 6. Effects of protease inhibitors on endoCAM integrity.  Bo- 
vine endothelial cells were extracted in TNC buffer (see Materials 
and Methods) containing a mixture of protease inhibitors including 
1 #g/ml leupeptin, 1 #g/ml pepstatin, 5 mM EDTA, and 5 mM DFP 
(lanes A and B) or 2 mM PMSF (lane C) and subjected to SDS- 
PAGE on 7% gels under nonreducing conditions and transferred to 
nitrocellulose for immunoblot analysis. Lanes A and C, immuno- 
blot using  polyclonal anti-endoCAM;  lane B,  immunoblot using 
monoclonal anti-endoCAM. 
Figure  7.  Immunoblot analysis of purified endoCAM  using anti- 
cadherin and anti-endoCAM antibodies.  EndoCAM  was purified 
from bovine endothelial cells by lectin and antibody affinity chro- 
matography. Equal amounts of material were subjected to SDS- 
PAGE on 7% gels under nonreducing conditions and silver stained 
or transferred to nitrocellulose for immunoblot analysis. Lane A, 
immunoblot using polyclonal anti-endoCAM; lane B, immunoblot 
using monoclonal anti-endoCAM; lane C, immunoblot using pre- 
immune serum; lane D, immunoblot using anti-pan-cadherin anti- 
body; lane E,  silver stain of purified endoCAM. 
(Volk and Geiger,  1986).  The differential protease sensitivi- 
ties of the epithelial  and  endothelial  cadherins  when  com- 
pared with endoCAM,  further document the differences be- 
tween these proteins  and  endoCAM. 
To explore  the  relationship  of endoCAM  to  the  protein 
identified by van Mourik et al. (1985) and the CD31 antigen, 
the ability of anti-endoCAM antibody to react with other cell 
types  was  studied.  The  anti-endoCAM  mAb  reacted  with 
proteins of a  similar size as seen in endothelial  cells in the 
extracts from bovine platelets (Fig.  5, middle).  A  more pre- 
cise comparison between endoCAM and the platelet protein 
reported by van Mourik et al. (1985) was not possible, as the 
mAb against this protein would not react with bovine mate- 
rial.  However, by using an mAb against CD31  (generously 
provided by Dr. Jan Sixma), it was possible to more directly 
determine if CD31 and endoCAM represented similar mole- 
cules and at the same time determine if endoCAM was pres- 
ent on white blood cells.  To accomplish this,  human  U937 
cells were labeled with [35S]methionine and immunoprecip- 
itated with preimmune serum, anti-CD31 mAb antibody and 
polyclonal  anti-endoCAM.  Fig.  10  shows  that  U937  cells 
contain a  130-kD protein recognized by the anti-CD31  mAb 
(Fig.  10 B) and that a  protein of the same size is identified 
with our anti-endoCAM antibody (Fig.  10 C). When the ex- 
tracts were adsorbed with anti-CD31  antibodies before im- 
munoprecipitation, no material:reactive with either CD31 or 
endoCAM remained (data not shown): Thus, endoCAM and 
CD31  appear to be related. 
Discussion 
The endothelium  is composed of a  dynamic group of cells 
organized along the inner  surface of blood vessels forming 
a  polarized,  nonthrombogenic,  highly  specialized  mono- 
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endothelial  cell  extracts  pread- 
sorbed with anti-endoCAM anti- 
bodies.  Nonionic  detergent  ex- 
tracts  from  bovine  endothelial 
cells were exhaustively immuno- 
precipitated with a mAb against 
endoCAM or a nonreactive con- 
trol mAb. The total cell extract 
(lanes marked A),  the  superna- 
tants preadsorbed with endoCAM 
(lanes marked B), or the supema- 
tants preadsorbed with irrelevant 
mAb (lanes marked C) were sub- 
jected to SDS-PAGE, and trans- 
ferred to nitrocellulose. All lanes 
were immunoblotted with either 
monoclonal anti-endoCAM (le~), 
polyclonal rabbit anti-endoCAM 
(middle)  or a  polyclonal rabbit 
anti-pan-cadhedn (right). The two 
molecular  higher  weight  bands 
seen in lane B, left,  represent re- 
sidual mouse antibodies reacting 
with  the  secondary  rabbit-anti- 
mouse antibodies used in the im- 
munoblot. 
layer. They possess well-defined junctional complexes that 
prevent the free flow of fluids between cells, but which also 
allow intercellular communication. They interact with plate- 
lets and leukocytes at sites of injury and in some cases pos- 
sess  receptors  required  for  lymphocyte homing  (Harlan, 
1985; Stoolman, 1989). Thus, endothelial cells must contain 
molecules which control endothelial cell interactions, ini- 
tiate the formation of polarity and junctional complexes and 
react with other cell types. The molecule isolated here, des- 
ignated endoCAM (endothelial Cell Adhesion Molecule) has 
properties that might be expected of a molecule involved in 
one or more of these processes. 
EndoCAM is concentrated at sites of endothelial cell-cell 
junctions both in culture and in tissue (Figs. 2 and 3). Immu- 
nohistochemistry suggests that endoCAM is found on endo- 
thelial cells lining major vessels, as well as capillaries.  In 
subconfluent cultures, endoCAM is seen by immunofluores- 
cence to be uniformly distributed over the cell surface. After 
the monolayer has  reached confluency, endoCAM is  seen 
only at regions of cell-cell contact. The concentration of en- 
doCAM in these regions appears to be a  specific response 
to contact with other endothelial cells. In mixed cultures of 
epithelial and endothelial cells,  the two cell types remain 
clearly segregated. However, at the point of endothelial-epi- 
thelial cell contact, endoCAM is not found, Suggesting that 
the molecules responsible for initiating intercellular adhe- 
sion on each cell type are functionally distinct (Albelda, 
S.  M., and L.  Romer, unpublished observations). 
EndoCAM is expressed at the cell surface, as evidenced 
by  the  fact  that  it  could  be  labeled  by  lactoperoxidase- 
catalyzed iodination (Fig.  1) and appears to be an integral 
membrane protein as it could only be extracted using deter- 
gents. Its function as an intercellular adhesion molecule was 
suggested by the fact that the polyclonal antibody specific for 
endoCAM was able to prevent the association of endothelial 
cells into a typical cobblestone-like monolayer. This effect 
was  blocked by purified endoCAM,  but not with extracts 
from which endoCAM was absent (Fig. 4). A similar assay 
was  used  to  detect the  presence of cadherins  on  epithe- 
lial cells in culture (Damsky et al.,  1983) and to implicate 
them in the initiation of cell-cell adhesion. These observa- 
tions suggest that endoCAM is involved in initial endothelial 
cell-cell adhesion, although its precise role remains to be de- 
termined.  Unlike anti-cadherin antibodies (Behrens et al., 
1985), however, addition of  anti-endoCAM antibodies do not 
disrupt confluent cell monolayers. 
The relationship of endoCAM to other known cellular ad- 
hesion molecules is an important issue. EndoCAM is not a 
member of the integrin family, despite the fact that two im- 
munoreactive  bands  are  frequently  seen  in  immunoblots 
(Fig. 6). It is not found in adhesion plaques (Fig. 2). It does 
not react with antibodies against any of the known integrin 
subunits (Albelda, S. M., and C. A. Buck, unpublished ob- 
servations), and immunoprecipitation analysis does not re- 
veal the presence of a second noneovalently associated sub- 
unit (Fig.  1). 
Superficially, endoCAM resembles a cadherin. It is simi- 
lar in size, intercellular location and possible biologic func- 
tion. Anti-endoCAM antibodies, like anti-cadherin antibod- 
ies block cell-cell interactions. However, endoCAM appears 
to  be  distinct  from known  cadherins by several criteria. 
First, an antibody that recognizes all known cadherins did 
not react with purified endoCAM (Fig. 7). Second, complete 
removal of all endoCAM from endothelial cell extracts by 
immunoadsorption did not remove any significant mount of 
material reactive with the anti-pan-eadherin antibody (Fig. 
8). Third, the two molecules exhibited different sensitivities 
to proteases (Fig. 9). Endothelial cells do, however, possess 
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1989). A similar interaction may occur in focal contact for- 
mation where proteoglycans and integrins must both bind to 
their  respective  ligands  before  a  stable  focal  contact  is 
formod (LeBaron et al.,  1988). 
The size,  location, and tissue distribution of endoCAM 
also suggest that it may be related to a previously described 
cell surface protein common to endothelial cells, granulo- 
cytes, monocytes, some lymphocytes and platelets (Ohto et 
al.,  1985; van Mourick et al.,  1985; Goyert et al.,  1986). 
This molecule has been designated CD31 (McMichael et al., 
1987). Ohto et al., (1985) further suggest that CD31  is in- 
volved  in  endotoxin-stimulated  granulocyte  chemotaxis. 
Like CD31, endoCAM is found on platelets and white cells. 
Immunoblot  analysis  of bovine  platelets  using  the  anti- 
endoCAM mAb revealed a cross-reacting protein of similar 
size to endoCAM (Fig. 5). Like endoCAM, this protein was 
rapidly degraded from  130 to  ,,o120 kD upon extraction. 
Similarly, both anti-endoCAM and anti-CD31 reacted with 
a 130-10) molecule on the surface of the human myelomono- 
cytic cell line U937 (Fig. 10). These data suggest that endo- 
CAM may also be related to the 135-kD protein described 
on human cells by Newman 0990) and Muller et al. (1989). 
This protein is an integral membrane protein restricted to the 
cell-cell borders of cultured human endothelial cells and en- 
dothelial cells in a variety of  tissue sections, but which is also 
present  on platelets  and  white  blood  cells.  We  have  ex- 
changed antibodies with these laboratories and shown that 
our polyclonal endoCAM antibody reacts with an identical 
protein  in  extracts  of human  endothelial  cells.  Although 
more rigorous analysis is still required to confirm the precise 
relationship  of CD31  and  endoCAM,  it  is  clear  that  an 
endoCAM-like molecule exists on platelets and white blood 
cells, and that these molecules are serologically related'. 
Several other molecules of similar size and tissue distri- 
bution  to  endoCAM  have been described.  These include 
PADGEM, a platelet activation-dependent granule-external 
Figure 9. Protease sensitivities of  endoCAM and cadherins. Bovine 
epithelial (MDBK) cells (A) or bovine endothelial cells (B and C) 
were exposed to 0.01% trypsin/EGTA (TE), EGTA (E), 0.0001% 
trypsin/EGTA (L/E) or trypsin plus calcium (/E') for 30 rain, ex- 
tracted with NP-40 and subjected to SDS-PAGE and immunoblot 
analysis. Group A, epithelial cell extracts immunoblotted with anti- 
pan-cadherin; group B, endothelial cells immunoblotted with anti- 
endoCAM; group C, endothelial cells immunoblotted with anti- 
pan-cadherin.  Molecular mass markers in kilodaltons are desig- 
nated on the left. 
a  protein that cross-reacts with the pan-cadherin antibody 
(Fig. 5). This finding supports a preliminary report by Hei- 
mark and Schwartz (1988) describing a potential endothelial 
cell cadherin. How endoCAM and the endothelial cadherins 
might function together to regulate endothelial cell-cell ad- 
hesion remains to be determined.  It is possible that they 
work cooperatively in the formation of initial cell-cell con- 
tacts. Such cooperativity would resemble that reported for 
adhesive interactions occurring between T  cells and their 
targets, where both integrins and T cell antigen recognition 
receptors must react with their respective ligands for effec- 
Figure  10.  Immunoprecipitation of human U937 cells with anti- 
endoCAM and anti-CD31 antibodies. Human U937 cells were la- 
beled with [35S]methionine  and immunoprecipitated with preim- 
mune serum 0ane A), a monoclonal antibody against CD31 (lane 
B), or anti-endoCAM polyclonal antibody (lane C). Both antibod- 
ies identify a protein migrating in the  130-kD region of the gel. 
Albelda et al. Endothelial Cell-Cell Adhesion Molecule  1235 membrane protein also known as GMP-140 that is found on 
platelets, megakaryocytes, and endothelial cells (Johnston et 
al., 1989; Larsen et al., 1989). However, the distribution of 
PADGEM, i.e. within the Weibel-Palade bodies (Bonfanti et 
al., 1989), clearly differentiates it from endoCAM. Structur- 
ally¢ PADGEM is similar to the endothelial leukocyte adhe- 
sion molecule ELAM-1  (Bevilacqua et al.,  1989)  and the 
murine lymphocyte homing receptor MEL-14 (Siegelman et 
al.,  1989).  These molecules all mediate the interaction of 
leukocytes or platelets with endothelial cells and hence could 
be at least functionally related to endoCAM. Whether undo- 
CAM is a member of this family of molecules remains to be 
determined. EndoCAM, however, is not restricted to certain 
types of endothelial cells as is MEL-14, and is constitutively 
expressed on endothelial cells, in contrast to ELAM-1  that 
is present only after endothelial cell activation, making it 
likely that endoCAM is distinct from these molecules. 
In summary, the data presented here suggest that endo- 
CAM functions in the endothelial cell-cell adhesion process 
and is likely related to the molecule defined by anti-CD31 
antibodies. The presence of endoCAM on leukocytes and 
platelets and the implication of an endoCAM-related mole- 
cule in chemotaxis (Ohto et al., 1985) suggest possible addi- 
tional functions. EndoCAM may well be among the many 
molecules involved in thrombogenesis and wound healing, as 
well as in leukocyte-endothelial cell interactions. Its precise 
role in these events and relationship to other molecules will 
be better understood once the complete cDNA sequence is 
known. 
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Note Added in Proof.  Newman et al. (1990) have recently cloned the human 
protein identified by anti-CD31 antibodies and found that it is a member 
of the immunoglobulin superfamily. In collaboration with this group, we 
have expressed the full-length eDNA encoding for PECAM-1  in COS-7 
cells and found that the protein produced localizes at cell-cell borders and 
cross-reacts with the polyelonal endoCAM antibody described here. This 
protein thus represents the human homologue of endoCAM.  (Newman, 
P. J., M. C. Berndt, J. Gorsk, G. C. White II, S. Lyman, C. Paddock, 
and W. A. Muller. 1990. Molecular cloning of PECAM-1 [CD31]: a novel 
member of the immunoglobulin gene superfamily expressed on human 
platelets and at endothelial cell intercellular junctions. Science [Wash. DC]. 
In press.) 
References 
AIbelda,  S. M., M. Daise, E. N. Levine, and C. A. Buck.  1989. Identification 
and characterization of cell-substratum adhesion receptors on cultured hu- 
man adult large vessel endothelial cells. J.  Clin. Invest.  83:1992-2002. 
Behrens, J., W. Birchmeier, S. L. Goodman, and B. A. Imhof. 1985. Dissocia- 
tion of Madin-Darby canine kidney epithelial  cells by the monoclonal anti- 
body anti-Are-l: mechanistic aspects and identification  of the antigen as a 
component related  to uvomorulin. J.  Cell Biol. 101:1307-1315. 
8evilacqua, M. P., S. Stengalin, M. A. Gimbrone, and B. Seed. 1989. Endothe- 
lial leukocyte adhesion molecule 1: an inducible receptor for neutrophiis re- 
lated to complement regulatory proteins and lectins. Science (Wash. DC). 
243:1160-1165. 
Bonfanti, R., B. C. Furie, B. Furie, and D. D. Wagner. 1989. PADGEM is 
a component of Weibel-Patade bodies in endothelial cells. Blood. 73: ! 109- 
1112. 
Damsky, C.  H., J.  Richa, D. Solter,  K. Knudsen, and C. A. Buck.  1983. 
Identification  and purification of a cell surface glycoprotein mediating inter- 
cellular adhesion in embryonic and adult tissue. Cell. 34:455-466. 
Dustin, M. L., and T. A. Springer.  1989. T-cell  receptor cross-linking tran- 
siently stimulates adhesiveness through LFA-I. Nature (Lond.). 341:619- 
624. 
Edelman, G. M. 1988. Morphoregulatory molecules. Biochemistry. 27:3533- 
3543. 
Fleming, T. P., and M. H. Johnson. 1988. From frog to epithelium. Annu. Bey. 
Cell. Biol. 4:459--485. 
Franke, W. W., P. Cowin, C. Grand, C. Kuhn, and H.-P. Kapprell.  1988. The 
endothelial junction. The plaque and its components. In Endothelial  Cell Bi- 
ology in Health and Disease. N. Simionescu and M. Simionescu, editors. 
Plenum Press, New York. pp 147-166. 
Goyert, S. M., E. M. Ferrero, S. V. Seremetis, R. J. Winchester, J. Silver, 
and A. C. Mattison. 1986. Biochemistry and expression of myelomonocytic 
antigens. J.  lmmunol.  137:3909-3914. 
Gumbiner, B., and K. Simons. 1986. A functional assay for proteins involved 
in establishing  an epithelial occluding barrier:  identification ofa uvomorulin- 
like polypeptide.  J.  Cell Biol. 102:457--468. 
Gumbiner, B., B. Stevenson, and A. Grimaldi. 1988. The role of the cell adhe- 
sion molecule uvomorulin in the formation and maintenance of the epithelial 
junctional complex. J.  Cell BioL  107:1575-1587. 
Harlan, J.  M.  1985.  Leukocyte-endothelial  interactions. Blood.  65:513-525. 
Hatta, K., T. S. Okada, and M. Takeichi. 1985. A monoclonal antibody disrupt- 
ing calcium-dependent cell-cell adhesion of brain tissues: possible role of its 
target antigen in animal pattern formation. Proc. Natl. Acad.  Sci. USA. 
82:2789-2793. 
Heimark, R. L., and S. M. Schwartz. 1988. Endothelial  morphogenesis. In En- 
dothelial  Cell Biology in Health and Disease. N. Simionescu and M. Simio- 
nescu, editors. Plenum Press, New York.  123-143. 
Jaffe, S., P. D. Oliver, S. M. Farocoqui, P. L. Novak, N. Sorgente, and V. K. 
Kalra.  1987. Separation  of luminal and abluminal membrane enriched do- 
mains from cultured bovine aortic endothelial cells: monoclonal antibodies 
specific  for endothelial cell  plasma membranes. Biochim.  Biophys.  Acta. 
898:37-52. 
Jarrell, B., E. Levine, S. Shapiro, S. Williams, R. A. Carabasi, S. Mueller, 
and S. Thornton. 1984. Human adult endothelial  cell growth in culture. J. 
Vasc. Surg. 1:757-764. 
Johnston, G. I., R. G. Cook, and R. P. McEver.  1989. Cloning of GMP-140, 
a granule membrane protein of platelets and endothelium: sequence similar- 
ity to proteins involved in cell adhesion and inflammation. Cell. 56:1033- 
1044. 
Knudsen, K. A., P. Rao, C. H. Damsky, and C. A. Buck.  1981.  Membrane 
glycoproteins involved in cell-substratum adhesion. Proc. Natl. Acad.  Sci. 
USA. 78:6071-6075. 
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage "I"4. Nature  (Lord.).  227:680--685. 
Larsen, E., A. Celli, G. E. Gilbert, B. Furie, J. K. Ethan, R. Bonfanti, D. D. 
Wagner, and B. Furie.  1989.  PAl)GEM protein:  a receptor that mediates 
the interaction  of activated platelets with neutrophils and monocytes. Cell. 
59:305  -312. 
LeBaron, R~ G., J. D. Esko, A. Woods, S. Johansson, and M. Hook.  1988. 
Adhesion o f glycosaminoglycan-deficient  chinese hamster  ovary cell mutants 
to fibronectin  substrata. J.  Cell Biol. 106:945-952. 
McMichael, A. J., et al., editors.  1987.  Leukocyte Typing IIL  White Cell 
Differentiation  Antigens. Oxford University Press, Oxford, UK. 1050 pp. 
Muller, W. A., C. M. Ratti, S. L. McDonnell, and Z. A. Cohn. 1989. A human 
endothelial  cell-restricted  externally disposed plasmalemmal protein  en- 
riched in intercellular junctions. J. Exp.  Mud.  170:399-414. 
Ohto, H., H. Maeda, Y. Shibata, R.-F., Chert, Y. Ozaki, and M. Higashihara. 
1985. A novel leukocyte differentiation  antigen: two monoclonal antibodies 
TM2 and TM3 define a i 30-kd molecule present on neutrophils, monocytes, 
platelets, and activated lympboblasts. Blood.  66:873-881. 
Pasdar,  M.,  and W. J.  Nelson.  1988.  Kinetics of desmosorne assembly in 
Madin-Darby canine kidney epithelial  cells: temporal and spatial regulation 
of desmoplakin organization and stabilization  upon cell-cell contact. I. Bio- 
chemical analysis. J.  Cell Biol.  106:677-685. 
Richa, J., C. H. Damsky, C. A. Buck, B. B. Knowles, and D. SoRer.  1985. 
Cell surface glycoproteins mediate compaction, trophoblast attachment, and 
endoderm formation during early mouse development. Dev. Biol. 108:513- 
521. 
Rosen, E. M., S. N. Muller, J. P. Noveral, and E. M. Levine. 1983. Prolifera- 
tive  characteristics of clonal  endothelial  cell  strains. J.  Cell. Physiol. 
107:123-137. 
Rutislmuser, U., and T. M. JesseU. 1988. Cell adhesion molecules in vertebrate 
neural development. Biol. Rev. 68:819-857. 
Schneeherger, E. E., and R, D. Lynch. 1984. Tight junctions: their structure, 
composition, and function. Circ. Res.  5:723-733. 
Siegelman, M. H., M. van de Rijn, and I. L. Weissman, 1989. Mouse lymph 
node homing receptor cDNA clone encodes for a glycoprotein revealing tan- 
dem interaction  domains. Science (Wash. DC). 243:1156-1172. 
Stoolman, L. M. 1989. Adhesion molecules controlling lymphOcyte migration. 
Cell. 56:909-910. 
Takeichi, M. 1977. Functional correlation between cell adhesive properties and 
some cell surface proteins. J.  Cell Biol. 75:464-474. 
The Journal of Cell Biology, Volume 110,  1990  1236 Takeichi, M. 1988. The cadherins: cell-cell adhesion molecules controlling ani- 
mal morphogenesis.  Development.  102:639-655. 
Thornton,  S. C., S. N. Mueller, and E. M. Levine.  1983. Human endothelial 
cells:  use of heparin  in cloning  and  long-term  serial cultivation.  Science 
(Wash. DC). 222:623-625. 
van Mourik,  J.  A., O. C.  Leeksma,  J. H.  Reinders,  P.  G. de Grnot,  and J. 
Zandbergen-Spaargaren.  1985. Vascular  endothelial  cells  synthesize  a 
plasma membrane protein indistinguishable from the platelet membrane pro- 
tein IIa. J.  Biol. Chem. 260:11300-11306. 
Volk, T., and B. Geiger.  1986. A-CAM: a 135-kD receptor of intercellular ad- 
herens junctions. I. Immunoelectron microscopic localization and biochemi- 
cal studies. J.  Cell Biol. 103:1441-1450. 
Albelda et al. Endothelial Cell-Cell  Adhesion Molecule  1237 